disease-free survival rate at 1 year during the study conduct [clinicaltrials_resource:d493d1b91ea605743ddd3bd441b57f6f]

disease-free survival rate at 1 year during the study conduct [clinicaltrials_resource:d493d1b91ea605743ddd3bd441b57f6f]

Preoperative docetaxel-cisplatin combination chemotherapy
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:d493d1b91ea605743ddd3bd441b57f6f
clinicaltrials:NCT00132639
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

disease-free survival rate at 1 year during the study conduct [clinicaltrials_resource:d493d1b91ea605743ddd3bd441b57f6f]

Preoperative docetaxel-cisplatin combination chemotherapy
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:d493d1b91ea605743ddd3bd441b57f6f
Bio2RDF identifier
d493d1b91ea605743ddd3bd441b57f6f
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d493d1b91ea605743ddd3bd441b57f6f
measure [clinicaltrials_vocabulary:measure]
disease-free survival rate at 1 year
time frame [clinicaltrials_vocabulary:time-frame]
description
Preoperative docetaxel-cisplatin combination chemotherapy
identifier
clinicaltrials_resource:d493d1b91ea605743ddd3bd441b57f6f
title
disease-free survival rate at 1 year during the study conduct
@en
inDataset
type
label
disease-free survival rate at ...... 3d1b91ea605743ddd3bd441b57f6f]
@en